Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

UNCY
Unicycive Therapeutics, Inc. Common Stock
stock NASDAQ

At Close
Mar 11, 2026 3:59:54 PM EDT
7.06USD+1.583%(+0.11)231,446
7.03Bid   7.06Ask   0.03Spread
Pre-market
Mar 11, 2026 9:12:30 AM EDT
7.00USD+0.719%(+0.05)10,453
After-hours
Mar 11, 2026 4:50:30 PM EDT
7.00USD-0.803%(-0.06)3,412
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
10:12AM EST  Unicycive Therapeutics Granted European Patent Titled 'Rare earth metal compounds, methods of making, and methods of using the same (for use in GI tract or bloodstream to remove phosphate or for treatment of hyperphosphatemia)'   Benzinga
Jan 10, 2022
07:01AM EST  Unicycive Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual   PR Newswire
Nov 30, 2021
04:13PM EST  Unicycive Therapeutics Receives FDA Guidance On Renazorb Regulatory Pathway   Benzinga
Nov 29, 2021
07:10AM EST  Unicycive Therapeutics Receives Confirmatory Guidance On Renazorb Regulatory Pathway   Benzinga
07:01AM EST  Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory   PR Newswire
Nov 11, 2021
09:27AM EST  Unicycive Therapeutics Q3 Net Loss $5.2 Mln Or $0.37/shr Vs Net Loss $0.7 Mln Or $0.08/shr Prior Year   RTTNews
09:15AM EST  Unicycive Therapeutics Q3 EPS $(0.37) Down From $(0.08) YoY   Benzinga
09:15AM EST  Unicycive Therapeutics Announces Third Quarter 2021 Financial Results   PR Newswire
Oct 26, 2021
07:31AM EDT  Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President,   PR Newswire
Sep 15, 2021
06:22AM EDT  Unicycive Therapeutics to Be Added to Russell Microcap Index   Benzinga
Sep 7, 2021
06:01AM EDT  Unicycive Therapeutics to Present at the H.C. Wainwright 23rd Annual Global   PR Newswire
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 16, 2021
06:10AM EDT  Unicycive Therapeutics Q2 EPS $(0.13) Down From $(0.04) YoY   Benzinga
06:03AM EDT  Unicycive Therapeutics Q2 Net Loss $1.1 Mln Or $0.13/Shr Vs Loss Of $0.3 Mln Or $0.04/Shr Last Year   RTTNews
06:01AM EDT  Unicycive Therapeutics Announces Second Quarter 2021 Financial Results   PR Newswire
Aug 9, 2021
10:24AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021   Benzinga
09:58AM EDT  Roth Capital Initiates Coverage On Unicycive Therapeutics with Buy Rating, Announces Price Target of $13.5   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 15, 2021
08:08AM EDT  The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs   Benzinga
Jul 14, 2021
10:30AM EDT  Mid-Morning Market Update: Markets Open Higher; Citigroup Earnings Beat Expectations   Benzinga
07:48AM EDT  The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues   Benzinga
Jul 13, 2021
10:47AM EDT  Unicycive Therapeutics Shares Open For Trade At $8.55; IPO Priced $5/Share   Benzinga
10:04AM EDT  Unicycive Therapeutics Shares Will Open For Quote At 10:35 a.m. EDT, Expected To Open For Trade After 10:45 a.m. EDT; IPO Priced $5/Share   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC